Characterization of Neurensin-2 knockout mice: insights into stress-resilience mechanisms.

IF 5.8 1区 医学 Q1 PSYCHIATRY
Hadas Catane Hovav, Ofer Yitzhak Kashi, Yumna Abu Ghanem, Naomi Stochinsky, Laila Agbariya, Hila Yehuda, Moriya Weitz-Aviv, Saja Baraghithy, Joseph Tam, Rami Yaka, Gali Umschweif
{"title":"Characterization of Neurensin-2 knockout mice: insights into stress-resilience mechanisms.","authors":"Hadas Catane Hovav, Ofer Yitzhak Kashi, Yumna Abu Ghanem, Naomi Stochinsky, Laila Agbariya, Hila Yehuda, Moriya Weitz-Aviv, Saja Baraghithy, Joseph Tam, Rami Yaka, Gali Umschweif","doi":"10.1038/s41398-025-03448-7","DOIUrl":null,"url":null,"abstract":"<p><p>Major depressive disorder (MDD) affects millions worldwide, yet its pathophysiology remains poorly understood. While some individuals are susceptible to developing depression, others show resilience that protects them from developing MDD. Understanding the resilience-associated mechanisms will likely result in novel therapies for MDD. We have recently reported that the vesicular protein Neurensin-2 mediates depression and that its deletion confers profound resilience to chronic stress. Nonetheless, the behavioral and molecular adaptations that underlie the stress resilience in Neurensin-2 knockout mice are still unknown. In this study, we aimed to comprehensively characterize the basal behavioral effects of Neurensin-2 deletion in mice. We used Neurensin-2 knockout male and female mice to examine how Neurensin-2 deletion affects cognitive, emotional, and motor performance in mice. In addition, we examined the impact of Neurensin-2 deletion on body weight, analyzed the stress-induced molecular changes, and tested how these changes affect the excitatory/inhibitory balance. We found that while Neurensin-2 deletion confers basal anxiolysis and weight reduction, no discernible cognitive, social, or motor impairments were detected. Furthermore, we found that Neurensin-2 knockout mice have impaired hippocampal inhibitory transmission, which is resilient to the stress-evoked excitatory/inhibitory imbalance seen in wild-type mice. Our findings suggest that Neurensin-2 deletion confers basal anxiolysis, and shifts the hippocampal excitatory/inhibitory balance. These effects are not accompanied by impaired cognitive function or weight gain. Thus, we suggest Neurensin-2 inhibition as an exciting potential strategy for developing treatments for depression and anxiety disorders as well as for promoting stress resilience.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"225"},"PeriodicalIF":5.8000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223177/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03448-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Major depressive disorder (MDD) affects millions worldwide, yet its pathophysiology remains poorly understood. While some individuals are susceptible to developing depression, others show resilience that protects them from developing MDD. Understanding the resilience-associated mechanisms will likely result in novel therapies for MDD. We have recently reported that the vesicular protein Neurensin-2 mediates depression and that its deletion confers profound resilience to chronic stress. Nonetheless, the behavioral and molecular adaptations that underlie the stress resilience in Neurensin-2 knockout mice are still unknown. In this study, we aimed to comprehensively characterize the basal behavioral effects of Neurensin-2 deletion in mice. We used Neurensin-2 knockout male and female mice to examine how Neurensin-2 deletion affects cognitive, emotional, and motor performance in mice. In addition, we examined the impact of Neurensin-2 deletion on body weight, analyzed the stress-induced molecular changes, and tested how these changes affect the excitatory/inhibitory balance. We found that while Neurensin-2 deletion confers basal anxiolysis and weight reduction, no discernible cognitive, social, or motor impairments were detected. Furthermore, we found that Neurensin-2 knockout mice have impaired hippocampal inhibitory transmission, which is resilient to the stress-evoked excitatory/inhibitory imbalance seen in wild-type mice. Our findings suggest that Neurensin-2 deletion confers basal anxiolysis, and shifts the hippocampal excitatory/inhibitory balance. These effects are not accompanied by impaired cognitive function or weight gain. Thus, we suggest Neurensin-2 inhibition as an exciting potential strategy for developing treatments for depression and anxiety disorders as well as for promoting stress resilience.

神经素-2敲除小鼠的特征:对应激恢复机制的见解。
重度抑郁障碍(MDD)影响着全世界数百万人,但其病理生理学仍然知之甚少。虽然有些人容易患上抑郁症,但其他人表现出的适应力保护他们免受重度抑郁症的影响。了解恢复相关的机制可能会导致新的治疗重度抑郁症的方法。我们最近报道了囊泡蛋白神经素-2介导抑郁,其缺失赋予对慢性应激的深刻恢复力。尽管如此,神经球蛋白-2基因敲除小鼠应激恢复能力背后的行为和分子适应机制仍然未知。在这项研究中,我们旨在全面表征神经素-2缺失对小鼠的基本行为影响。我们使用敲除Neurensin-2的雄性和雌性小鼠来研究Neurensin-2缺失如何影响小鼠的认知、情绪和运动表现。此外,我们研究了Neurensin-2缺失对体重的影响,分析了应激诱导的分子变化,并测试了这些变化如何影响兴奋/抑制平衡。我们发现,虽然神经球蛋白-2缺失带来了基础的焦虑缓解和体重减轻,但没有发现明显的认知、社交或运动障碍。此外,我们发现Neurensin-2敲除小鼠海马抑制传递受损,这是对野生型小鼠应激诱发的兴奋/抑制失衡的弹性。我们的研究结果表明,Neurensin-2缺失赋予了基础焦虑溶解,并改变了海马兴奋/抑制平衡。这些影响并不伴随着认知功能受损或体重增加。因此,我们建议神经素-2抑制作为一种令人兴奋的潜在策略,用于开发抑郁症和焦虑症的治疗方法,以及促进压力恢复能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.50
自引率
2.90%
发文量
484
审稿时长
23 weeks
期刊介绍: Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信